Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
For two consecutive years! Healthy Yuan & Lizhu have been selected again for the Hang Seng A-share Sustainable Development Company Benchmark Index.
Published Time：
2020-08-18
Recently, the quarterly review results of the Hang Seng Sustainable Development Enterprise Index series have been released. , Joincare Pharmaceutical Group Industry Co., Ltd. and its subsidiaries Lizhu Pharmaceutical Group Co., Ltd. have both been selected again as constituent stocks of the Hang Seng A-share Sustainable Development Enterprise Benchmark Index.
It is understood that the Hang Seng Sustainable Development Enterprise Index series was launched in 2010. This series includes a total of 5 indices, namely the Hang Seng Sustainable Development Enterprise Benchmark Index, the Hang Seng Sustainable Development Enterprise Index, the Hang Seng A-share Sustainable Development Enterprise Benchmark Index, the Hang Seng A-share Sustainable Development Enterprise Index, and the Hang Seng Mainland and Hong Kong Sustainable Development Enterprise Index. This index series is mainly used to evaluate the sustainable development performance of enterprises in three aspects: environment, society, and corporate governance. Being a constituent stock of this index series demonstrates the outstanding performance and investment value of the selected listed companies in sustainable development.
The selection process for constituent stocks of the Hang Seng Sustainable Development Enterprise Index series is scientific and rigorous. It strictly follows the sustainable development rating framework and research results designed by the independent professional assessment agency, Hong Kong Quality Assurance Agency. The sustainable development rating is assessed according to seven core indicators, including Corporate Governance (CG), Human Rights (HR), Labor Practices (LP), Environment (Env), Fair Operating Practices (FOP), Consumer Issues (CI), and Community Involvement and Development (CID). This makes the Hang Seng Sustainable Development Enterprise Index series objective, reliable, and highly investable, providing the investment market with an objective benchmark. Currently, only 135 excellent companies are included in the Hang Seng A-share Sustainable Development Enterprise Benchmark Index.
Healthyuan is a comprehensive pharmaceutical group company integrating R&D, production, sales, and services. It has a diversified R&D team and currently focuses on building technology platforms such as monoclonal antibodies, inhalation preparations, long-acting sustained-release microspheres, and nanolipid microemulsions. Recently, it has successively launched milestone domestic generic inhalation preparations such as "Shutanlin®", "Lishutong®", and "Wushu®". In recent years, under the leadership of Chairman Zhu Baoguo, the group has maintained excellent performance, explored the concept of sustainable development and innovation, and actively undertaken corporate social responsibility in social public welfare.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.